UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety of gadoxetate disodium: Results from the clinical phase II-III development program and postmarketing surveillance

Journal of magnetic resonance imaging, 2015-09, Vol.42 (3), p.634-643

2015

Volltextzugriff (PDF)

Diagnostic Performance and Description of Morphological Features of Focal Nodular Hyperplasia in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging: Results of a Multicenter Trial

Investigative radiology, 2008-07, Vol.43 (7), p.504-511

2008

Volltextzugriff (PDF)

Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients

Acta radiologica (1987), 2016-11, Vol.57 (11), p.1326-1333

2016

Volltextzugriff (PDF)

Radiologists and Clinical Trials: Part 1 The Truth About Reader Disagreements

Therapeutic innovation & regulatory science, 2021-11, Vol.55 (6), p.1111-1121

2021

Volltextzugriff (PDF)

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumine

Journal of magnetic resonance imaging, 2010-02, Vol.31 (2), p.356-364

2010

Volltextzugriff (PDF)

A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System

Magnetic Resonance in Medical Sciences, 2016, Vol.15(2), pp.227-236

2016

Volltextzugriff (PDF)

Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients:a multicenter,open-label,phase Ⅲ study

Hepatobiliary & pancreatic diseases international, 2013-12, Vol.12 (6), p.607-616

2013

Volltextzugriff (PDF)

Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)

Journal of magnetic resonance imaging, 2011-02, Vol.33 (2), p.409-416

2011

Volltextzugriff (PDF)

Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study

Magnetic Resonance Insights, 2015-01, Vol.2015 (2015), p.1-10

2015

Volltextzugriff (PDF)

Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications

Investigative radiology, 2016-09, Vol.51 (9), p.537-543

2016

Volltextzugriff (PDF)

Safety of Gadobutrol, a New Generation of Contrast Agents: Experience From Clinical Trials and Postmarketing Surveillance

Investigative radiology, 2011-11, Vol.46 (11), p.663-671

2011

Volltextzugriff (PDF)

Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment

Investigative radiology, 2011-09, Vol.46 (9), p.556-566

2011

Volltextzugriff (PDF)

Correction to "Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study"

Magnetic resonance insights, 2015-01, Vol.2015 (8), p.23-23

2015

Volltextzugriff (PDF)

Safety profile of gadoxetate disodium in elderly patients (≥65 years)

Acta radiologica (1987), 2018-01, Vol.59 (1), p.81-88

2018

Volltextzugriff (PDF)

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

Radiology, 2005-02, Vol.234 (2), p.468-478

2005

Volltextzugriff (PDF)

Efficacy and Safety of Gadobutrol (1.0 M) versus Gadopentetate Dimeglumine (0.5 M) for Enhanced MRI of CNS Lesions: A Phase III, Multicenter, Single-Blind, Randomized Study in Chinese Patients

Magnetic Resonance Insights, 2012-01, Vol.2012 (2012), p.17-28

2012

Volltextzugriff (PDF)

Vascular Enhancement in Early Dynamic Liver MR Imaging in an Animal Model: Comparison of Two Injection Regimen and Two Different Doses Gd-EOB-DTPA (Gadoxetic Acid) With Standard Gd-DTPA

Investigative radiology, 2009-06, Vol.44 (6), p.305-310

2009

Volltextzugriff (PDF)

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

Radiology, 2004-01, Vol.230 (1), p.266-275

2004

Volltextzugriff (PDF)

Gadobutrol in the central nervous system at three doses: Results from a phase II, randomized, multicenter trial

Journal of magnetic resonance imaging, 2014-02, Vol.39 (2), p.410-418

2014

Volltextzugriff (PDF)

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

Radiology, 2005-10, Vol.237 (1), p.89-98

2005

Volltextzugriff (PDF)

Magnetic Resonance Evaluation of Brain Metastases From Systemic Malignances With Two Doses of Gadobutrol 1.0 M Compared With Gadoteridol: A Multicenter, Phase II/III Study in Patients With Known or Suspected Brain Metastases

Investigative radiology, 2011-07, Vol.46 (7), p.411-418

2011

Volltextzugriff (PDF)

Evaluation of the Effect of Two Gadolinium-Containing Contrast-Enhancing Agents, Gadobutrol and Gadoxetate Disodium, on Colorimetric Calcium Determinations in Serum and Plasma

Investigative radiology, 2011-06, Vol.46 (6), p.366-369

2011

Volltextzugriff (PDF)

A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities

Journal of magnetic resonance imaging, 2015-02, Vol.41 (2), p.404-413

2015

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Radiology, Nuclear Medicine & Medical Imaging
(25)
Humans
(24)
Female
(18)
Male
(18)
Middle Aged
(17)
Adult
(16)
Magnetic Resonance Imaging
(14)
Contrast Media
(13)
Magnetic Resonance Imaging - Methods
(12)
Aged
(11)
Gadolinium Dtpa
(11)
Sensitivity And Specificity
(10)
Contrast Media - Adverse Effects
(8)
Liver
(8)
Aged, 80 And Over
(7)
Gadobutrol
(7)
Liver Neoplasms - Diagnosis
(7)
Liver Neoplasms - Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety of gadoxetate disodium: Results from the clinical phase II-III development program and postmarketing surveillance

Diagnostic Performance and Description of Morphological Features of Focal Nodular Hyperplasia in Gd-EOB-DTPA-Enhanced Liver Magnetic Resonance Imaging: Results of a Multicenter Trial

Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients

Radiologists and Clinical Trials: Part 1 The Truth About Reader Disagreements

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumine

A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System

Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients:a multicenter,open-label,phase Ⅲ study

Evaluation of possible drug-drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)

Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study

Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications

Safety of Gadobutrol, a New Generation of Contrast Agents: Experience From Clinical Trials and Postmarketing Surveillance

Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment

Correction to "Safety and Efficacy of Gadobutrol for Contrast-enhanced Magnetic Resonance Imaging of the Central Nervous System: Results from a Multicenter, Double-blind, Randomized, Comparator Study"

Detection and Characterization of Focal Liver Lesions: A Japanese Phase III, Multicenter Comparison Between Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging and Contrast-Enhanced Computed Tomography Predominantly in Patients With Hepatocellular Carcinoma and Chronic Liver Disease

Safety profile of gadoxetate disodium in elderly patients (≥65 years)

Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

Efficacy and Safety of Gadobutrol (1.0 M) versus Gadopentetate Dimeglumine (0.5 M) for Enhanced MRI of CNS Lesions: A Phase III, Multicenter, Single-Blind, Randomized Study in Chinese Patients

Vascular Enhancement in Early Dynamic Liver MR Imaging in an Animal Model: Comparison of Two Injection Regimen and Two Different Doses Gd-EOB-DTPA (Gadoxetic Acid) With Standard Gd-DTPA

Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings

Gadobutrol in the central nervous system at three doses: Results from a phase II, randomized, multicenter trial

Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study

Magnetic Resonance Evaluation of Brain Metastases From Systemic Malignances With Two Doses of Gadobutrol 1.0 M Compared With Gadoteridol: A Multicenter, Phase II/III Study in Patients With Known or Suspected Brain Metastases

Evaluation of the Effect of Two Gadolinium-Containing Contrast-Enhancing Agents, Gadobutrol and Gadoxetate Disodium, on Colorimetric Calcium Determinations in Serum and Plasma

A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities

Suchergebnisse filtern